Abstract
Pancreas transplantation uniquely offers patients with insulin-dependent diabetes (IDDM) the opportunity for prolonged normal glucose control. Advancements in the surgical and medical care of pancreas transplant (PTx) recipients led to remarkable improvements in patient and graft survival rates. This review focuses on the studies examining the changes in quality of life (QOL) after PTx. Initially, the various instruments used to assess both global and disease-specific QOL will be reviewed. As the majority of PTx are performed simultaneously with a kidney transplant (SPK), most of the available literature focuses on this population. Recent studies continue to support the view that SPK improves most aspects of QOL including general health and vitality, physical and mental health functions, social functioning, and diabetes-related issues. SPK also provides additive QOL benefits compared to kidney transplant (KTx) alone. SPK QOL benefits not only come in the year after the transplant but are maintained and increase in the years to follow. The few QOL studies in pancreas after kidney transplant (PAK) and pancreas transplant alone (PTA) recipients demonstrate that QOL improves posttransplant. A common theme is that loss of graft function results in a marked reduction in QOL. Fortunately, graft loss is becoming less frequent in the recent era.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kandaswamy R, Stock PG, Gustafson SK, et al. OPTN/SRTR 2018 annual data report: pancreas. Am J Transpl. 2020;20(Suppl 1):131–92.
Stratta RJ, Gruessner AC, Gruessner RWG. The past, present and future of pancreas transplantation in Diabetes Mellitus. Endoc Diab Metab J. 2018;2:1–9.
Gruessner AC, Gruessner RWG. Pancreas transplantation for the patients with type 1 and type 2 diabetes mellitus in the United States: a registry report. Gastroenterol Clin N Am. 2018;47:417–41.
Myint TM, O’Shaughnessy DV, Marshall S, et al. Health-related quality of life of patients awaiting kidney and simultaneous pancreas-kidney transplants. Nephrology. 2013;18:827–32.
Gross CR, Gruessner AC, Treesak C. Quality of life for pancreas recipients. In: Gruessner RWG, Sutherland DER, editors. Transplantation of the pancreas, vol. 17. Cham: Springer; 2005. p. 509–19.
Hanlon M, Cooper M, Abrams P. Quality of life after pancreas transplantation: time to look again. Curr Opin Organ Transpl. 2019;24:451–5.
Burra P, De Bona M, Germani G, et al. The concept of quality of life in Organ transplantation. Transpl Proc. 2007;39:2285–7.
Venkatanarasimhamoorthy AS, Barlow AD. Simultaneous pancreas-kidney versus living donor kidney transplantation alone: an outcomes-driven choice? Curr Diab Rep. 2018;18:67–71.
Dean PG, Kukla A, Stegall MD, et al. Pancreas transplantation. BMJ. 2017;357:1321–31.
WHO. Basic documents: forty-ninth edition (including amendments adopted up to 31 May 2019). Geneva: World Health Organization; 2020.
Piehlmeier W, Bullinger M, Kirchberger I, et al. Evaluation of the quality of life of patients with insulin-dependent diabetes mellitus before and after organ transplantation with the SF-36 health survey. Eur J Surg. 1996;162:933–40.
Test MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334:835–40.
Carr AJ, Gibson B, Robinson PG. Measuring quality of life: is quality of life determined by expectations or experience? Br Med J. 2001;322:1240–3.
Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 2016;4:1–12.
Grieco A, Long CJ. Investigation of the Karnofsky performance status as a measure of quality of life. Health Psychol. 1984;3:129–42.
O’Boyle CA, Mc Gee H, Hickey A, et al. Individual quality of life in patients undergoing hip replacement. Lancet. 1992;339:1088–91.
Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end stage renal disease. N Engl J Med. 1985;312:553–9.
Dew MA. Quality-of-life studies: organ transplantation research as an exemplar of past progress and future directions. J Psychosomat Res. 1998;44:189–95.
Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–21.
Wolfe RA, McCullough KP, Schaubel DE, et al. Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transpl. 2008;8:997–1011.
Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113–28.
Allison T, Wong G, McTaggart S, et al. Quality of life of young adults and adolescents with chronic kidney disease. J Pediatr. 2013;163:1179–85.
Whiting JF, The Transplantation Outcomes Research Group. Standards for economic and quality of life studies in transplantation. Transplantation. 2000;70:1115–21.
Kharroubi SA, Brazier JE, Roberts J, et al. Modelling SF-6D health state preference data using a nonparametric Bayesian method. Health Econ. 2007;26:597–612.
Hays RD, Kallich JD, Mapes DL, et al. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res. 1994;3:329–38.
Busija L, Pausenberger E, Haines TP, et al. Adult measures of general health and health-related quality of life. Arthritis Care Res. 2011;63:S383–412.
Rabin R, Charro F. EQ-5D: a measure of health status from the Euro Qol Group. Ann Med. 2001;33:337–43.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.
Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13:1203–10.
Horsman J, Furlong W, Feeny D, et al. The health utilities index (HUI): concepts, measurement properties and applications. Health Qual Life Outc. 2003;1:1–13.
Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med. 1988;27:1411–4.
McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York, NY: Oxford University Press; 1996.
University of California San Diego. Quality of well being scale. Health poly project, 0622. La Jolla, CA: School of Medicine, Department of Family and Preventative Medicine, University of California San Diego; 1991.
Kaplan RM, Qiankun Q, Ries A, et al. Quality of well-being outcomes in the national emphysema treatment trial. Chest. 2015;147:377–87.
Von der Lippe N, Waldum B, Brekke FB, et al. From dialysis to transplantation: a 5-year longitudinal study on self-reported quality of life. BMC Nephrol. 2014;15:191–9.
Laupacis A, Pus N, Muirhead N, et al. Disease specific questionnaire for patients with a renal transplant. Nephron. 1993;64:226–31.
Franke GH, Reimer J, Kohnle M, et al. Quality of life in end-stage renal disease patients after successful kidney transplantation – development of the ESRD symptom checklist transplantation module. Nephron. 1999;83:31–9.
The DCCT Research Group. Reliability and validity of a diabetes quality-of-life measure for the Diabetes Control and Complications Trial (DCCT). Diabetes Care. 1988;11:725–32.
Gross CC, Scain SF, Scheffel R, et al. Brazilian version of the problem areas in diabetes care (B-PAID): validation and identification of individuals at high risk for emotional distress. Diabetes Res Clin Pract. 2007;76:455–9.
Nyumura I, Babazono T, Tauchi E, et al. Quality of life in Japanese patients with type 1 diabetes and end-stage renal disease undergoing simultaneous pancreas and kidney transplantation. Diabetol Int. 2017;8:268–74.
Romano Posegger K, Linhares MM, Mucci S, et al. The quality of life in type 1 diabetic patients with end-stage kidney disease before and after simultaneous pancreas-kidney transplantation: a single center prospective study. Transpl Int. 2020;33:330–9.
Clarke WL, Cox DJ, Gonder-Frederick LA, et al. Reduced awareness of hypoglycemia in adults with IDD: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18:517–22.
Kleinman L, Kilburg A, Machinicki G, et al. Using GI-specific patient outcomes measures in renal transplant patients: validation of the GSRS and GIQLI. Qual Life Res. 2006;15:1223–32.
Becker BN, Becker YT, Odorico JS, et al. Simultaneous pancreas-kidney and pancreas transplantation. Minerva Urol Nephrol. 2002;54:213–26.
Jiang AT, Rowe N, Sener A, et al. Simultaneous pancreas-kidney transplantation: the role in the treatment of type 1 diabetes and end-stage renal disease. Can Urol Assoc J. 2014;8:135–8.
Joseph JT, Baines LS, Morris MC, et al. Quality of life after kidney and pancreas transplantation: a review. Am J Kidney Dis. 2003;42:431–45.
Sutherland DER, Gruessner R, Dunn D, et al. Lessons learned from the more than 1,000 pancreas transplants at a single institution. Ann Surg. 2001;233:463–501.
Barlow AD, Saeb-Parsy K, Warson CJE. An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK transplant registry study. Transpl Int. 2017;30:884–92.
Lo A, Stratta RJ, Hathaway DK, et al. Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic bladder drainage. Am J Kidney Dis. 2001;38:132–43.
Esmeijer K, Hoogeveen EK, van den Boog PJM, et al. Superior long-term survival for simultaneous pancreas-kidney transplantation as renal replacement therapy: 30 year-year follow up of a nationwide cohort. Diabetes Care. 2020;43:321–8.
Scalea JR, Cooper M. Current concepts in simultaneous transplantation of kidney and pancreas. J Intensive Care Med. 2012;27:199–206.
Al-Qaoud TM, Odorico JS, Redfield RR III. Pancreas transplantation in type 2 diabetes: expanding the criteria. Curr Opin Organ Transpl. 2018;23:454–60.
Rohan V, Taber D, Palanisamy A, et al. Impact of Type 1 and Type 2 diabetes mellitus on pancreas transplant outcomes. Exp Clin Transpl. 2019;6:796–802.
Martins LS, Outerelo C, Fonseca IM, et al. Health-related quality of life may improve after transplantation in pancreas-kidney recipients. Clin Transpl. 2015;29:242–51.
Scheuermann U, Rademacher S, Jahn N, et al. Impact of pretransplant dialysis modality on the outcomes and health-related quality of life of patients after simultaneous pancreas-kidney transplantation. Health Qual Life Outcomes. 2020;18:303–11.
Smith GC, Trauer T, Kerr PG, et al. Prospective quality-of-life monitoring of simultaneous pancreas and kidney transplant recipients using the 36-item short form health survey. Am J Kidney Dis. 2010;55:698–707.
Suzuki A, Kenmochi T, Maruyama M, et al. Evaluation of quality of life after simultaneous pancreas and kidney transplantation from living donors using the short form 36. Transpl Proc. 2008;40:2565–7.
Kwiatkowski A, Michalak G, Czerwinski J, et al. Quality of life after simultaneous pancreas-kidney transplantation. Transpl Proc. 2005;37:3558–9.
Jurgensen JS, Ulrich C, Horstrup JH, et al. Sexual dysfunction after simultaneous pancreas-kidney transplantation. Transpl Proc. 2008;40:927–30.
Rosen RC, Riley RC, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822.
Muehrer RJ, Keller MI, Powwattana A, et al. Sexuality among women recipients of a pancreas and kidney transplant. West J Nurs Res. 2006;28:137–50.
Sureshkumar KK, Patel BM, Markatos A, et al. Quality of life after organ transplantation in type 1 diabetes with end-stage renal disease. Clin Transpl. 2006;20:19–25.
Dunn TB. Life after pancreas transplantation: reversal of diabetic lesions. Curr Opin Organ Transpl. 2014;19:73–9.
Knight RJ, Daly L. The impact of pancreas transplantation on the patient employment opportunities. Clin Transpl. 2004;18:49–52.
Nijhoff MF, Hovens JGFM, Huisman SD, et al. Psychological symptoms and quality of life after simultaneous kidney and pancreas transplantation. Transpl Dir. 2020;6:e552.
Degrogatis LR, Melisaratos N. The brief symptom inventory: an introductory report. Psychol Med. 1983;13:595–605.
Van Kampen D, De Beurs E, Andrea H. A short form of the dimensional assessment of personality pathology-basic questionnaire (DAPP-BQ): the DAPP-SF. Psychiatry Res. 2008;160:115–28.
Pera PI, Vasallo JM, Rabasa AT, et al. Quality of life in simultaneous pancreas-kidney transplant recipients. Clin Transpl. 2009;23:600–5.
Grochowiecki T, Szmidt J, Galazka Z, et al. The comparison of treatment results of Type 1 diabetes mellitus complicated by end-stage diabetic nephropathy in patients undergoing simultaneous pancreas and pre-emptive kidney transplantation (SPPKTx) and patients enrolled into the dialysis program – a cohort study. Ann Transpl. 2005;10:31–5.
Ziaja J, Bozek-Pasjak D, Krol R, et al. Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients. Transpl Proc. 2009;41:3156–8.
Sureshkumar KK, Mubin T, Mikhail N, et al. Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis. 2002;39:1300–6.
Drognitz O, Benz S, Pfeffer F, et al. Long-term follow up of 78 simultaneous pancreas-kidney transplants at a single-center institution in Europe. Transplantation. 2004;78:1802–8.
Douzdjian V, Ferrara D, Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness analysis model. Am J Kidney Dis. 1998;31:794–802.
Shingde R, Calisa V, Craig J, et al. Relative survival and quality of life benefits of pancreas-kidney transplantation, deceased kidney transplantation and dialysis in type 1 diabetes mellitus – a probabilistic simulation model. Transpl Int. 2020;33:1393–404.
Stratta RJ, Gruessner AC, Odorico JA, et al. Pancreas transplantation: an alarming crisis in confidence. Am J Transpl. 2016;16:2556–62.
Humar A, Ramcharan T, Kandaswamy R, et al. Pancreas after kidney transplants. Am J Surg. 2001;182:155–61.
Niederhaus SV. Pancreas transplant alone. Curr Opin Organ Transpl. 2015;20:115–20.
Scalea JR, Pettinato L, Fiscella B, et al. Successful pancreas transplantation alone is associated with excellent self-identified health score and glucose control: a retrospective study from a high-volume center in the United States. Clin Transpl. 2018;32(2):e13177.
Scalea JR, Butler CC, Munivenkatappa RB, et al. Pancreas transplant alone as an independent risk factor for the development of renal failure: a retrospective study. Transplantation. 2008;86:1789–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pankewycz, O.G., Gross, C.R., Laftavi, M.R., Gruessner, A.C. (2023). Quality of Life. In: Gruessner, R.W.G., Gruessner, A.C. (eds) Transplantation of the Pancreas. Springer, Cham. https://doi.org/10.1007/978-3-031-20999-4_74
Download citation
DOI: https://doi.org/10.1007/978-3-031-20999-4_74
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-20998-7
Online ISBN: 978-3-031-20999-4
eBook Packages: MedicineMedicine (R0)